NASDAQ NMS - GLOBAL MARKET · BBOT
+1.43% · +$0.1300 · Vol 171.6K
Market closed · last close 4:00 PM ET · price as of 19:56:11 ET
BridgeBio Oncology Therapeutics Inc

BridgeBio Oncology Therapeutics Inc

Biotechnology
$9.21
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
BBOT
BridgeBio Oncology Therapeutics Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BBOT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BBOT catalysts
About BridgeBio Oncology Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2025
Employees
88
Country
US

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.19
Day high
$9.44
Day low
$9.03
Previous close
$9.08
52W high
$13.73
-32.92% from high
52W low
$7.12
32% of range
Market cap
$728M
EPS
$-1230.1500
Beta
1.29
Shares out
80.2M
Volume
171.6K
0.59× rel vol
Avg volume
288.6K
VWAP
$9.15
Price history computed in-house
1W
+1.88%
1M
+4.42%
3M
+10.04%
1Y
+4.19%
YTD
-26.44%
SMA 50 $8.45 · above
SMA 200 $9.96 · below
52W position 32%

BBOT overview

Veridion Score
49
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BBOT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BBOT Form 4 filings
Public disclosures

Congress activity in BBOT

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BBOT in the cached public ledger.

Federal contracts

BBOT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BBOT in this window.
Lobbying spend

BBOT lobbying filings, year to date.

Registered lobbying filings matched to BridgeBio Oncology Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BBOT in this window.
Loading news for BBOT
Analyst ratings
Sovereign unlock shows live analyst consensus for BBOT.
Options
Sovereign unlock shows live options positioning for BBOT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.